Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype nonalcoholic steatohepatitis (NASH) are becoming the leading cause of liver-related …
Cancer alters the function of multiple organs beyond those targeted by metastasis,. Here we show that inflammation, fatty liver and dysregulated metabolism are hallmarks of …
S Daemen, A Gainullina, G Kalugotla, L He, MM Chan… - Cell reports, 2021 - cell.com
Macrophage-mediated inflammation is critical in the pathogenesis of non-alcoholic steatohepatitis (NASH). Here, we describe that, with high-fat, high-sucrose-diet feeding …
The progression from gestation into lactation represents the transition period, and it is accompanied by marked physiological, metabolic, and inflammatory adjustments. The entire …
Obesity is the most common cause of insulin resistance, and the current obesity epidemic is driving a parallel rise in the incidence of T2DM. It is now widely recognized that chronic …
Nonalcoholic fatty liver disease is the most prevalent liver disease worldwide, affecting 20%– 25% of the adult population. In 25% of patients, nonalcoholic fatty liver disease progresses …
S Lim, JW Kim, G Targher - Trends in Endocrinology & Metabolism, 2021 - cell.com
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a chronic condition characterized by hepatic fat accumulation combined with underlying metabolic …
Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. Despite its high prevalence, only a small …
Gene expression data have become increasingly important in machine learning and computational biology over the past few years. In the field of gene expression analysis …